Danaher Corp (DHR)

Stay informed with Danaher Corp (DHR) share price and insights to guide your trading strategy. Stay updated with FP Markets Australia.

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Danaher Corp (DHR) Profile

Danaher Corporation develops, manufactures, and promotes products and services for the professional, medical, industrial, and commercial industries worldwide. Life Sciences, Diagnostics, and Environmental & Applied Solutions are the company's three divisions. The Life Sciences section manufactures mass spectrometers; tools for cellular analysis, laboratory automation, and centrifugation; microscopes; and genomics consumables.

Additionally, this division provides bioprocess technologies, consumables, and services, as well as filtration, separation, and purification technologies to pharmaceutical and biopharmaceutical, food and drinks medical and life sciences companies, as well as universities, medical schools, and research organisations, as well as various industrial producers. Diagnostics include goods in chemistry, immunoassay, microbiology, and automation, as well as hematology and molecular diagnostics. This sector provides analytical techniques, reagents, consumables, software, and consulting to hospitals, physician offices, reference laboratories, and many other critical care settings.

Diagnostics offers items in chemistry, immunoassay, microbiology, and automation, and other hematological and molecular diagnostics. This division provides analytical instruments, reagents, consumables, software, and support to hospitals, physician offices, reference laboratories, and other critical care facilities. Danaher Corporation is headquartered in Washington, the District of Columbia. Market Cap 218.182B USD. Full-Time Employees: 67,000. Stock price as of 1/12/2022 305.33+2.30 (+0.76%) USD At close: 04:00 PM EST. Total assets for the quarter ending September 30, 2021, were $82.498B USD.

Danaher Corp (DHR.xnys) News At Danaher, associated health and well-being are of the utmost importance. Our Global Response Team is continuously monitoring, planning for, and managing our global COVID-19 company response 24 hours a day, 7 days a week, in accordance with instructions from international health organizations, local governments, and our own safety measures. Operating Companies are assembling regional response teams to carry out global directives. Along with safety measures, Danaher has programs and tools in place to assist associates' physical, financial, and emotional wellness. Throughout this trying time, Danaher associates and leaders around the world continue to exemplify what it means to live a shared purpose - assisting people in realizing their potential.

Danaher Corp (DHR.xnys) Analysis One critical factor in identifying winning stocks is to look for a stock with a Relative Strength Rating of 80 or greater. Danaher (DHR), a manufacturer of medical and industrial devices, meets the bill. Danaher's latest RS Rating of 84 indicates that the stock has outperformed 84% of all equities over the last year. Market history indicates that stocks that go on to achieve better gains typically start with an RS Rating of at least 80.

Start Trading Danaher Corp (DHR) with a Market Leader Today

Danaher Corp (DHR) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram